Literature DB >> 20349903

Congenital ptosis and amblyopia.

Yesim Oral1, Ozlen Rodop Ozgur, Levent Akcay, Mehmet Ozbas, Omer Kamil Dogan.   

Abstract

PURPOSE: To investigate the incidence and causes of amblyopia in congenital ptosis.
METHODS: The frequency and causes of amblyopia were evaluated in 83 eyes of 72 patients with congenital ptosis. Patient ages ranged between 10 months and 70 years. Amblyopia was defined as best-corrected visual acuity of 0.7 or less. After a complete ophthalmologic examination, the amount of ptosis and levator function was determined and the following amblyogenic factors were identified: ametropia, anisometropia, and strabismus. In cases with no other reason for amblyopia, stimulus deprivation amblyopia due to ptosis was assumed.
RESULTS: The amount of ptosis was mild in 5 (6%), moderate in 26 (31%), and severe in 52 (63%) of 83 eyes with congenital ptosis. Strabismus was present in 17 (20%) eyes. Visual acuity could not be determined in 10 of 83 eyes with ptosis in children younger than 4 years. The overall incidence of amblyopia in the remaining 73 eyes was 48%. Of those patients with amblyopia, 54% had refractive errors such as anisometropia or ametropia, 20% had strabismus with or without refractive errors, and 26% had amblyopia solely attributed to ptosis. When all eyes with ptosis were included, the rate of stimulus deprivation amblyopia was 12% and all of these eyes had severe ptosis.
CONCLUSION: Early detection and treatment of amblyogenic factors such as refractive errors and strabismus is recommended and, when the pupillary axis is occluded with severe ptotic eyelids, surgery should be performed as soon as possible to prevent stimulus deprivation amblyopia. Copyright (c) 2010, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 20349903     DOI: 10.3928/01913913-20100308-08

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  9 in total

1.  An epidemiologic analysis of the association between eyelid disorders and ocular motility disorders in pediatric age.

Authors:  Matteo Ripa; Giovanni Cuffaro; Pia Clara Pafundi; Paola Valente; Remo Battendieri; Luca Buzzonetti; Roberta Mattei; Stanislao Rizzo; Gustavo Savino
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

2.  Increased Risk of Refractive Errors and Amblyopia among Children with Ptosis: A Nationwide Population-Based Study.

Authors:  Ning-Yi Hsia; Li-Yen Wen; Ching-Ying Chou; Cheng-Li Lin; Lei Wan; Hui-Ju Lin
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

3.  Amblyopia in childhood eyelid ptosis.

Authors:  Gregory J Griepentrog; Nancy Diehl; Brian G Mohney
Journal:  Am J Ophthalmol       Date:  2013-02-18       Impact factor: 5.258

Review 4.  The relationship between anisometropia and amblyopia.

Authors:  Brendan T Barrett; Arthur Bradley; T Rowan Candy
Journal:  Prog Retin Eye Res       Date:  2013-06-15       Impact factor: 21.198

5.  Safety and Long-term Outcomes of Congenital Ptosis Surgery: A Population-Based Study.

Authors:  Ali Mokhtarzadeh; Elizabeth A Bradley
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2016-06-07       Impact factor: 1.402

6.  Refractive error characteristics in patients with congenital blepharoptosis before and after ptosis repair surgery.

Authors:  Ji-Sun Paik; Su-Ah Kim; Shin Hae Park; Suk-Woo Yang
Journal:  BMC Ophthalmol       Date:  2016-10-08       Impact factor: 2.209

Review 7.  Clinical presentation and management of congenital ptosis.

Authors:  Marco Marenco; Ilaria Macchi; Iacopo Macchi; Emilio Galassi; Mina Massaro-Giordano; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2017-02-27

8.  Factors related to amblyopia in congenital ptosis after frontalis sling surgery.

Authors:  Youn-Shen Bee; Pei-Jhen Tsai; Muh-Chiou Lin; Ming-Ying Chu
Journal:  BMC Ophthalmol       Date:  2018-11-21       Impact factor: 2.209

9.  [Congenital ptosis: experience of a tertiary Moroccan center and latest development].

Authors:  Hanan Handor; Zouheir Hafidi; Moulayzahid Bencherif; Youssef Amrani; Adil belmokhtar; Mina Laghmari; Rajae Daoudi
Journal:  Pan Afr Med J       Date:  2014-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.